Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A4386 Elesclomol (STA-4783)3 CitationSummary: Oxidative stress/apoptosis inducer,potent and novel
-
A4388 XL-8881 CitationTarget: HSP90Summary: Hsp90 inhibitor
-
A3178 AN-2728Summary: PDE4 inhibitor,anti-inflammatory compound
-
A3215 AZD7687Target: DGATSummary: DGAT inhibitor,potent and selective
-
A8723 GSK180Target: Kynurenine-3-monooxygenaseSummary: inhibitor of kynurenine-3-monooxygenase (KMO)
-
B6036 INCB-024360Target: IDOSummary: potent and selective inhibitor of IDO1
-
B5963 7-EthoxyresorufinTarget: Cytochrome P450 (CYP450)Summary: Specific subtrate of CYP1A
-
B5508 Alda 1Target: Aldehyde DehydrogenasesSummary: ALDH2 activator
-
B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4 inhibitor,potent and selective
-
B4900 Indoximod (NLG-8189)Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor